The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ESMO 2022 | Areas of unmet need for patients with NSCLC and brain metastases

Name: Areas of unmet need for patients with NSCLC and brain metastases
Uploaded: 2022-09-12T00:00:00Z
Duration: 40 s
Description: Alessandra Bearz, MD, CRO National Cancer Institute, Aviano, Italy, describes current unmet needs for oncogene addicted patients with NSCLC and brain metastases, including elucidating the most effective therapies for first-line treatment as well as strategies to overcome resistance. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

Alessandra Bearz • 12 Sep 2022

ESMO 2022

Lung Cancer Non-Small Cell Lung Cancer

Alessandra Bearz, MD, CRO National Cancer Institute, Aviano, Italy, describes current unmet needs for oncogene addicted patients with NSCLC and brain metastases, including elucidating the most effective therapies for first-line treatment as well as strategies to overcome resistance. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.